Stay updated on Zoetis Press Releases

Sign up to get notified when there's something new on the Zoetis Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Zoetis Press Releases page

  1. Check
    4 days ago
    Change Detected
    Summary
    The press releases page now features two November 2026 announcements: USDA licensing of Cytopoint Plus, a 75-day allergic-itch treatment for dogs, and CFO/COO Jay Saccaro’s upcoming appearance at the Jefferies Global Healthcare Conference.
    Difference
    1%
    Check dated 2026-11-12T12:48:37.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A new November 5, 2026 press release announces Zoetis’s third-quarter 2026 results, including revenue, earnings, and segment performance. It also highlights progress in innovation and revised full-year revenue and adjusted EPS guidance.
    Difference
    0.7%
    Check dated 2026-11-05T13:43:46.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Zoetis announced FDA approval of Convenia RTU for dogs, a single-injection antibiotic treatment for susceptible bacterial skin infections that can provide up to 14 days of treatment.
    Difference
    0.7%
    Check dated 2026-10-22T14:28:36.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The press-release listing now includes October 2026 announcements about Iris Knobloch joining Zoetis’ Board of Directors, Zoetis being named to Fortune’s Europe workplace list, and a $0.53-per-share fourth-quarter dividend.
    Difference
    2%
    Check dated 2026-10-15T15:31:34.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    A new October 6, 2026 press release reports laboratory study findings comparing Simparica Trio and NexGard Plus against a resistant heartworm isolate. It highlights higher efficacy and fewer infected dogs in the Simparica Trio-treated group.
    Difference
    0.7%
    Check dated 2026-10-08T15:24:13.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Zoetis UK announces Lenivia® (izenivetmab injection) launch in Great Britain, a long-acting antibody therapy delivering up to three months of osteoarthritis pain relief for dogs. This update adds the product launch news and date to the press releases page.
    Difference
    0.7%
    Check dated 2026-10-01T15:52:56.000Z thumbnail image

Stay in the know with updates to Zoetis Press Releases

Enter your email address, and we'll notify you when there's something new on the Zoetis Press Releases page.